SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-22-008804
Filing Date
2022-03-04
Accepted
2022-03-04 17:06:29
Documents
121
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A fgen-10ka_20211231.htm   iXBRL 10-K/A 4453847
2 EX-23.1 fgen-ex231_8.htm EX-23.1 2065
3 EX-31.1 fgen-ex311_9.htm EX-31.1 9396
4 EX-31.2 fgen-ex312_10.htm EX-31.2 9545
5 EX-32.1 fgen-ex321_7.htm EX-32.1 6938
  Complete submission text file 0001564590-22-008804.txt   20911562

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA fgen-20211231.xsd EX-101.SCH 124530
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fgen-20211231_cal.xml EX-101.CAL 113424
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fgen-20211231_def.xml EX-101.DEF 496953
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20211231_lab.xml EX-101.LAB 872211
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20211231_pre.xml EX-101.PRE 813476
115 EXTRACTED XBRL INSTANCE DOCUMENT fgen-10ka_20211231_htm.xml XML 5260551
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36740 | Film No.: 22715116
SIC: 2834 Pharmaceutical Preparations